Article info
Clinical and epidemiological research
Extended report
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis
- Correspondence to Juha Risteli, Institute of Diagnostics, Department of Clinical Chemistry, University of Oulu, PO Box 5000, FI-90014 Oulu, Finland; juha.risteli{at}oulu.fi
Citation
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis
Publication history
- Received September 30, 2011
- Accepted January 31, 2012
- First published March 14, 2012.
Online issue publication
September 10, 2012
Article Versions
- Previous version (14 March 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions